CE认证
美塑疗法
Pluryal Hair Density is a sterile, ready-to-use, CE-marked injectable polynucleotide (PN) biostimulator, formulated for scalp and hair regeneration. It is reserved for medical practitioners only and is indicated for hair loss conditions such as androgenetic alopecia and telogen effluvium, as well as for support after hair transplantation. The product contains 15 mg of polynucleotides per 2 mL syringe (7.5 mg/mL) and is intended strictly for professional use.
主要优势： Pluryal Hair Density
- Supports follicular stimulation through activation of dermal papilla cell activity
- Improves hair cycle dynamics, increasing the anagen/telogen ratio and reducing premature miniaturisation
- Provides anti-inflammatory action, reducing inflammatory mediators in the scalp
- Supports microcirculation, enhancing local perfusion, oxygenation and nutrient supply
- Promotes structural reinforcement around the follicle bulge, helping reduce hair shedding
- CE-marked Class III medical device for professional use
适应症与专业用途
主要适应症
- Androgenetic alopecia (in women and men)
- Telogen effluvium
- Adjuvant therapy: post-hair-transplant support, LED light and PRP
专业用途
Pluryal Hair Density is a class III medical device for professional use only, reserved for trained medical practitioners. It is administered by intradermal injection into the deep dermis of the scalp using a microbolus, multi-puncture or linear threading technique. Indicated for androgenetic alopecia, telogen effluvium and as adjuvant therapy after hair transplant, LED light or PRP. For androgenetic alopecia the protocol is 10 sessions over 4 months, followed by monthly maintenance.
治疗部位
- Scalp: frontotemporal region, mid-scalp and vertex
- Eyebrows
- Beard
适用患者
Suitable for adult men and women across androgenetic alopecia stages I-IV, with telogen effluvium, or requiring post-transplant support, following clinical assessment. A clinical study of 20 patients (10 men, 10 women; mean age 37.7 ± 8.1) published in the Archives of Dermatological Research reported a significant reduction in hair shedding, an increased anagen/telogen ratio, a 24.2% increase in terminal hairs at week 24 and improved hair thickness, with only mild, transient adverse effects and no serious adverse events.
作用原理： Pluryal Hair Density
Pluryal Hair Density works through polynucleotides at 7.5 mg/mL, injected intradermally into the scalp to activate metabolic pathways and A2A purinergic receptors that promote dermal papilla cell activity. This supports improved hair cycle dynamics, reduces inflammatory mediators, enhances local microcirculation, and promotes structural reinforcement around the follicle bulge, together supporting scalp and hair regeneration in androgenetic alopecia, telogen effluvium and post-transplantation recovery.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 PLURYAL 产品，来自经过严格审核的供应商，具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地，以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果，并提供专属售后支持，让您安心无忧。
常见问题
On which areas is Pluryal Hair Density used?
The scalp (the frontotemporal region, mid-scalp and vertex) as well as the eyebrows and beard, for androgenetic alopecia, telogen effluvium and post-hair-transplant support.
Is there clinical evidence for Pluryal Hair Density?
Yes. A clinical study of 20 patients with androgenetic alopecia, published in the Archives of Dermatological Research, reported a significant reduction in hair shedding, an increased anagen/telogen ratio and a 24.2% increase in terminal hairs at week 24, with no serious adverse events.
How many sessions of Pluryal Hair Density are needed?
For androgenetic alopecia the recommended course is 10 intradermal sessions over 4 months, followed by monthly maintenance. For telogen effluvium the course is 3 monthly sessions, repeated after 6 months if needed.
更多产品： MD Skin solutions Laboratoires
皮肤填充剂
生物活化
诊所替代选择
医美护肤
/ 最近浏览
继续浏览
Pluryal Hair Density is a sterile, ready-to-use, CE-marked injectable polynucleotide (PN) biostimulator, formulated for scalp and hair regeneration. It is reserved for medical practitioners only and is indicated for hair loss conditions such as androgenetic alopecia and telogen effluvium, as well as for support after hair transplantation. The product contains 15 mg of polynucleotides per 2 mL syringe (7.5 mg/mL) and is intended strictly for professional use.
主要优势： Pluryal Hair Density
- Supports follicular stimulation through activation of dermal papilla cell activity
- Improves hair cycle dynamics, increasing the anagen/telogen ratio and reducing premature miniaturisation
- Provides anti-inflammatory action, reducing inflammatory mediators in the scalp
- Supports microcirculation, enhancing local perfusion, oxygenation and nutrient supply
- Promotes structural reinforcement around the follicle bulge, helping reduce hair shedding
- CE-marked Class III medical device for professional use
适应症与专业用途
主要适应症
- Androgenetic alopecia (in women and men)
- Telogen effluvium
- Adjuvant therapy: post-hair-transplant support, LED light and PRP
专业用途
Pluryal Hair Density is a class III medical device for professional use only, reserved for trained medical practitioners. It is administered by intradermal injection into the deep dermis of the scalp using a microbolus, multi-puncture or linear threading technique. Indicated for androgenetic alopecia, telogen effluvium and as adjuvant therapy after hair transplant, LED light or PRP. For androgenetic alopecia the protocol is 10 sessions over 4 months, followed by monthly maintenance.
治疗部位
- Scalp: frontotemporal region, mid-scalp and vertex
- Eyebrows
- Beard
适用患者
Suitable for adult men and women across androgenetic alopecia stages I-IV, with telogen effluvium, or requiring post-transplant support, following clinical assessment. A clinical study of 20 patients (10 men, 10 women; mean age 37.7 ± 8.1) published in the Archives of Dermatological Research reported a significant reduction in hair shedding, an increased anagen/telogen ratio, a 24.2% increase in terminal hairs at week 24 and improved hair thickness, with only mild, transient adverse effects and no serious adverse events.
作用原理： Pluryal Hair Density
Pluryal Hair Density works through polynucleotides at 7.5 mg/mL, injected intradermally into the scalp to activate metabolic pathways and A2A purinergic receptors that promote dermal papilla cell activity. This supports improved hair cycle dynamics, reduces inflammatory mediators, enhances local microcirculation, and promotes structural reinforcement around the follicle bulge, together supporting scalp and hair regeneration in androgenetic alopecia, telogen effluvium and post-transplantation recovery.
为什么选择在 Allpara 订购
Allpara 提供正品、经过验证的 PLURYAL 产品，具备完整的批次可追溯性、CE认证库存、欧盟范围内快速配送以及专业的售后支持。
常见问题
On which areas is Pluryal Hair Density used?
The scalp (the frontotemporal region, mid-scalp and vertex) as well as the eyebrows and beard, for androgenetic alopecia, telogen effluvium and post-hair-transplant support.
Is there clinical evidence for Pluryal Hair Density?
Yes. A clinical study of 20 patients with androgenetic alopecia, published in the Archives of Dermatological Research, reported a significant reduction in hair shedding, an increased anagen/telogen ratio and a 24.2% increase in terminal hairs at week 24, with no serious adverse events.
How many sessions of Pluryal Hair Density are needed?
For androgenetic alopecia the recommended course is 10 intradermal sessions over 4 months, followed by monthly maintenance. For telogen effluvium the course is 3 monthly sessions, repeated after 6 months if needed.
更多产品： MD Skin solutions Laboratoires
查看制造商 →* 专业用途产品。包装可能因批次或市场而异。完整的使用说明和禁忌症请参阅随附的使用说明书。